research fund


immunology and virology


Eureka research fund for immunology and virology is initiated by Eureka TechIN to support the research innovation activities which address the emerging health concerns.


There is an initial commitment of $500K of fund, which will support 3 fields of research: 

  • Immunity

  • Stem cell

  • Antivirus & anti-bacteria

Eureka TechIN will manage this research fund through the process of application review, monitoring and evaluation to generate the R&D outcomes.

We closely work with our advisory board, which consists of experts in medical research and health services/practices, to maintain the high quality of the research. 

advisory board

A/Prof. David Anderson

Deputy Director of Burnet Institute

Head of Global Health Diagnostics Development Laboratory

Founder and CEO of Nanjing BioPoint Diagnostics

Dr. Ruchong Ou

Senior Research Fellow of Monash University

Senior Research Fellow of Alfred Hospital

Prof. Paul Hertzog

Director of the Centre for Innate Immunity and Infectious Diseases

Deputy Director of the Hudson Institute of Medical Research

Founder of the Victoria Infection and Immunity Network


The Eureka research grant can be used for

  • Fellowship

  • Collaboration

  • Seed grant

  • Research acceleration


With the rapid development of COVID-19 virus, the call for first round of application will be focused on anti-virus research.

To be eligible for our research grant, your project must be based in Australia.


2nd round call open date to be announced soon.

Express of Interest


Although the first-round EOI is closed, please do not hesitate to email us if you have any inquiry

Connect with us on WeChat

Customer Service

Official Account

Find our office

Level 19, 357 Collins Street, Melbourne, Australia 

Follow us on Linkedin


(+61) 3 9629 6131

1207314009389168677emergency telephone b

©Copyright 2020 Eureka Technology Innovation & Investment Pty Ltd.